Columbia Microbiome Sciences is developing a patent-pending photoprotection platform designed to complement conventional UV protection by supporting the skin’s biological response to environmental stress. The Bronxville, New York-based company says the technology is intended to move beyond a traditional “block, absorb, repeat” approach by targeting cellular, molecular and microbial mechanisms involved in skin resilience and recovery.
CEO Steven Rosenfeld is scheduled to present the company’s latest data on October 8, 2026, at the New York Chapter of the Society of Cosmetic Chemists’ symposium, “The Skin Barrier as a Living Interface: Biology, Disruption, and Repair.” The event, chaired by Roger McMullen, will take place from 9 a.m. to 6 p.m. at The Legacy Castle in Pequannock Township, New Jersey.
The platform arrives amid continued growth in the sun care category and increasing industry interest in skin longevity. According to the company, the global UV protection market is growing at more than 5% annually and is projected to reach $19.6 billion by 2032, driven in part by demand for premium and prestige products.
Rather than positioning photoprotection solely around UV filtration, Columbia Microbiome Sciences is investigating whether topical formulations can help skin better withstand and respond to the biological consequences of UV exposure.
The company's system incorporates proprietary components intended to work across several biological pathways. According to Columbia Microbiome Sciences, the technology is designed to:
- Stabilize DNA, RNA and antioxidant pathways during environmental stress
- Modulate immune responses and preserve signaling involved in skin recovery
- Reduce downstream effects associated with cumulative photodamage
- Support overall skin resilience during environmental exposure
The approach reflects a broader shift in skin care toward formulations that address not only individual signs of damage, but also the underlying biological processes associated with skin aging and barrier function.
“Sunscreen chemistry hasn’t fundamentally changed in more than 50 years,” Rosenfeld said. “Our system moves photoprotection from passive UV filtration to active biological support across the skin’s molecular, cellular, and microbial layers.”
The company says its technology is intended to function alongside the skin’s natural renewal processes rather than disrupting them. That positioning places the platform at the intersection of several areas of current skin care R&D, including microbiome science, cellular signaling, antioxidant defense and skin barrier biology.
The company says preliminary internal evaluations indicate potential advantages compared with conventional sunscreen formulations, particularly in relation to long-term skin health and visible signs of aging associated with chronic sun exposure. The company did not provide detailed study methodology, numerical results or independent validation in the announcement.
